• Global expansion strategy: The company plans to add 40 to 50 clinics annually in India, 10 to 15 in the Philippines, and enter a new country every 12 to 18 months to drive a 15% to 20% revenue CAGR over the next 3 to 4 years.
• Saudi market entry: NephroPlus launched an operational 25-bed clinic in Riyadh and partnered 51:49 with Al Faisaliah Group to bid for government reimbursement tenders, with outcomes expected over the next two to four quarters.
• Philippines market consolidation: Generating $110 per session compared to $22 in India, the Philippines is the company's primary revenue growth driver, where it is consolidating 18 local entities into five to reduce operational complexity.
• Talent supply pipeline: To address staffing constraints that account for 25% of revenue in employee costs, the company leverages training academies in India and the Philippines to supply nurses and technicians for domestic and international clinics.